| Trau, Dieter (Ayoxxa 201209 CSO of Ayoxxa Bisoystems GmbH) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Ayoxxa (Group) |
Germany |
| Traulsen, Fridtjof (Boehringer Ingelheim 201806 Corporate SVP Development) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Trautner, Else Beth (Euro Diagnostica 201101– CEO before CCO before AdvanDx + Dako + Life Technologies) |
Chief Executive Officer (CEO) |
Euro Diagnostica (Group) |
Sweden |
| Trautwein, Axel (Bayer 201404 Head of Chemical Crop Protection Research at Bayer CropScience) |
n. a. |
Bayer (Group) |
Germany |
| Travers, Stuart (Sentinel Oncology 201605 COO) |
Chief Operating Officer (COO) |
Sentinel Oncology Ltd. |
United Kingdom (GB) |
| Travis, Ben (Calibre Scientific 202303 CEO) |
Chief Executive Officer (CEO) |
Calibre Scientific (Group) |
United States (USA) |
| Traynor, Pete (Thermo Fisher 201403 Process Mass Spectrometry Market Leader) |
n. a. |
Thermo Fisher (Group) |
United States (USA) |
| Treco, Doug (Ra Pharmaceuticals 20008– CEO + Co-Founder before Transkaryotic Therapies) |
Chief Executive Officer (CEO) |
UCB (Group) |
United States (USA) |
| Trede, Dennis (SCiLS GmbH 201212– Managing Director + Steinbeis 201201 Deputy Managing Director SCiLS Bremen) |
Managing Director |
Bruker (Group) |
Germany |
| Treder, Martin (Affimed 201701 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Affimed (Group) |
Germany |
| Treffer, Udo (MultiSynTech 200902 CEO) |
Chief Executive Officer (CEO) |
MultiSynTech GmbH |
Germany |
| Tregay, Steven (Mission BioCapital 202409 Managing General Partner formerly Forma Therapeutics + Novartis Venture Fund) |
Chief Executive Officer (CEO) |
Mission BioCapital (with Mission Bay Capital) (Group) |
United States (USA) |
| Tremblay, Marc (Thermo Fisher 201211 President Clinical Diagnostics business) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
| Tremmel, Robin (Heidelberg Delivery Technologies 201707– Managing Director) |
Managing Director |
Heidelberg Delivery Technologies GmbH |
Germany |
| Trendelenburg, Chr. |
n. a. |
Städtische Kliniken Frankfurt a. M. |
Germany |
| Trengove, Robert (Murdoch Univ 201207 Prof + Director Separation Science + Metabolomics Lab) |
Professor |
Murdoch University |
Australia |
| Trepte, Claudia (Measurement Valley 201104 Managing Director) |
Managing Director |
Measurement Valley e. V. |
Germany |
| Treptow, Rainer (Eppendorf Instrumente 200609 CEO) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Germany |
| Tressel, Jürgen (Bruker 201710 Head of Tissue Pathology Business Unit at Bruker Daltonics) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
| Trexler, David R. (MorphoSys 201902– President of MorphoSys US Inc before EMD Serono + Eisai Inc + Mylan Bertek) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
United States (USA) |
| Triacca, Valentina (Lymphatica Medtech 202012 COO + Co-Founder) |
Chief Operating Officer (COO) |
Lymphatica Medtech (Group) |
Switzerland |
| Triebsch, Carola (Deutsche Messe 2013) |
Event Manager / Conference Manager |
Deutsche Messe AG |
Germany |
| Trinh, An (Sigma-Aldrich 200904 Product Sample Prep at Supelco) |
Product Manager (personnel) |
Merck (DE) (Group) |
|
| Trinker, Martin (ACIB GmbH 202208 Director Business Development + Fundraising) |
Business Development Manager / Strategy Manager |
ACIB GmbH – Austrian Centre of Industrial Biotechnology |
Austria |
| Triomphe, Thomas (Sanofi 202112 EVP Global Head of Sanofi Pasteur) |
President/Director/Head Business Group/Unit/Division |
Sanofi (Group) [since May 2011] |
|
| Tripathi, Vineeta (Vitarka Therapeutics 2021– CEO + Founder before Boehringer Ingelheim + Ipsen Bioinnovation) |
Chief Executive Officer (CEO) |
Vitarka Therapeutics Ltd. |
United Kingdom (GB) |
| Tripatzis, Ioannis |
n. a. |
Medical Park Hannover GmbH |
Germany |
| Tripet, Jean-Philippe (Aravis 200205 Managing Director + Board of Directors ESBATech) |
Managing Partner (investment firm) |
Aravis (Group) |
Switzerland |
| Tripp, Thorsten H. (Brand 200705 Sales Representative Asia/Pacific) |
Sales Manager / Marketing Manager |
Brand (Group) |
Germany |
| Tristram, Leo W. (RiNA GmbH 199912–201004– Managing Director+ PLS-Design GmbH 201201 Managing Director) |
Managing Director |
Biotechrabbit (Group) |
Germany |
| Tritschler, Lars (Nanoscribe 2018– CFO) |
Chief Executive Officer (CEO) |
RAG (Group) |
Germany |
| Trockle, Jochen (Trockle Unternehmensberatung 201207 Managing Director + Founder) |
Managing Director |
Trockle Unternehmensberatung GmbH & Co. KG |
Germany |
| Troia, Ken (Biotest 200908 Director Marketing Global Business Unit Microbiology) |
Sales Manager / Marketing Manager |
Grifols (Group) |
Germany |
| Trojer, Patrick (Triana Biomedicines 202410 CEO + Board Chair at Booster Therapeutics) |
Chief Executive Officer (CEO) |
|
|
| Trombe, Emmanuelle (McDermott Will & Emery 201701 Partner in Life Sciences Group in Paris) |
Attorney / Lawyer |
McDermott Will & Emery (MWE) (Group) |
France |
| Trost, Matthias (Univ Newcastle 201702 Professor at ICaMB) |
Professor |
University of Newcastle (Newcastle University) |
|
| Truehart, Tricia (Trout Group 201712) |
Public Relations Manager / Investor Relations Manager |
PNC Financial Services (Group) |
United States (USA) |
| Truex, Samantha (Upstream Bio CEO before Quench Bio + Synlogic + Padlock Therapeutics) |
Chief Executive Officer (CEO) |
Upstream Bio (US) |
United States (USA) |
| Truitt, Ed (Lubris 201206 CEO) |
Chief Executive Officer (CEO) |
Lubris LLC |
United States (USA) |
| Trummer, Christopher (Venga Ventures 202407 Founder + Celeris Therapeutics 202202 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Celeris Therapeutics (CelerixTx) (Group) |
Austria |
| Trutnau, Hans-H. (Kinomics 200507) |
n. a. |
Kinomics GmbH |
Germany |
| Trüeb, Hans Rudolf (Walder Wyss 202009 Senior Partner + Dinaqor 202009– General Counsel + Corporate Secretary) |
Attorney / Lawyer |
Walder Wyss AG |
Switzerland |
| Tryggvason, Kristian (Alder Therapeutics 202402 CEO formerly BioLamina 201303 CEO) |
Chief Executive Officer (CEO) |
Alder Therapeutics AB |
Sweden |
| Tröndle, Norbert (Genaxxon BioScience 200512) |
n. a. |
Genaxxon BioScience GmbH |
Germany |
| Trösken, Volker (Amedo 201003 Managing Director) |
Managing Director |
Amedo Smart Tracking Solutions GmbH |
Germany |
| Tsai, Charles (Cytena 201907 CEO of Cytena Bioprocess Solutions Co Ltd) |
Chief Executive Officer (CEO) |
Bico (Group) |
Taiwan |
| Tsai, John (Novartis 201908 Head Global Drug Development + CMO) |
Research & Development Manager |
Novartis (Group) |
Switzerland |
| Tsaioun, Katya (Akttyva Therapeutics 202302 Co-Founder + Board Member) |
Board member |
Akttyva Therapeutics Inc. |
United States (USA) |
| Tsao, Doris (Univ of Bremen 200610) |
n. a. |
University of Bremen |
Germany |
| Tschaharganeh, Darjus (DFKZ 202110 Group Lead + Prof at Univ Heidelberg) |
President/Director/Head of Research Organisation/Unit |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Tscheppe, Michael (Nuvonis 201802 Managing Director + Co-Founder) |
Managing Director |
Nuvonis Technologies GmbH |
Austria |
| Tschudin, Marie-France (Novartis 201906– President Novartis Pharmaceuticals joined 2017 before 10y at Celgene) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
| Tschöp, Matthias H. (Helmholtz 202001 CEO at Helmholtz Zentrum München) |
President/Director/Head of Research Organisation/Unit |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Tsunaba, Kazunari (Novartis 202003 President + Representative Director Novartis Pharma) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Japan |
| Tsybin, Yuri (Spectroswiss 202211 CEO + Founder before EPFL 201005 Professor) |
Professor |
Spectroswiss (Group) |
Switzerland |
| Tuason, Nico (Fluidigm 201502 Senior Product Manager) |
Product Manager (personnel) |
Standard BioTools (Group) |
United States (USA) |
| Tudorica, Joanne (Trophic Communications 201801 before MacDougall Biomedical Communications) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Tuffs, Annette (Helmholtz 201710 Head of Communications Dept at MDC) |
Public Relations Manager / Investor Relations Manager |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Tullman, Stephen (Ceptaris Therapeutics 201308 CEO) |
Chief Executive Officer (CEO) |
Johnson & Johnson (JnJ) (Group) |
United States (USA) |
| Tulstrup, Søren (Hansa Biopharma 2018– CEO formerly Galenica + Shire + Santaris Pharma) |
Chief Executive Officer (CEO) |
Hansa Biopharma AB |
Sweden |
| Tur, Christelle (Debiopharm 201504 Communications Coordinator) |
Public Relations Manager / Investor Relations Manager |
Debiopharm (Group) |
Switzerland |
| Turco, Davide (Indaco Venture 202205 Managing Director) |
Managing Director |
Indaco Venture (Group) |
Italy |
| Turgut, Kaya (Turgut Ilaç 201511 Board Chairman + Founder) |
Board member |
Turgut Ilaçlari A.S. |
Turkey |
| Turner, Heather (Carmot Therapeutics 202312 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Turner, Jonathan David (XL Technology Group 2005– SVP BusDev before Boehringer Head Corp BusDev before AstraZeneca) |
Managing Director |
Caprotec Bioanalytics GmbH |
Germany |
| Turner, Nat (Flatiron Health 201802 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Turner, Rodney (Ayoxxa 201612– CEO before interim CEO + Supervisory Board Member before Life Technologies + Evotec) |
Chief Executive Officer (CEO) |
Ayoxxa (Group) |
Germany |
| Turner, Simon (Alacrita 201706) |
Consultant (economic/technology) |
Alacrita (Group) |
United Kingdom (GB) |
| Turner, Simon (Sofinnova 202303 Partner at Sofinnova Partners) |
Partner (venture partner) |
Sofinnova (Group) |
France |
| Turner, Stephen (Steve) (Protea Biosciences 201002 CEO) |
Chief Executive Officer (CEO) |
Protea Biosciences (Group) |
United States (USA) |
| Tuschl, Thomas (Rockefeller Univ 200601) |
Professor |
Rockefeller Universtiy, Tuschl Lab Laboratory of RNA Molecular Biology |
United States (USA) |
| Tynes, Thomas E. (MeVis 200709–201204 Exec Board Director Marketing + Sales before Invivo Corp RESIGNED 4/12) |
Chief Commercial Officer (CCO) |
Varian Medical Systems (Group) |
Germany |
| Türeci, Özlem (BioNtech 202208 CMO formerly Ganymed 200811 CEO + CSO) |
Chief Executive Officer (CEO) |
Astellas (Group) |
Germany |
| Tyrekidis, Joanna (Noshaq 201906 Investment Manager) |
Investment Manager |
Noshaq S.A. |
Belgium |
| Tysiak, Michael (Cytolon 201504– CEO before Biobase 200110– joined as CFO became Managing Director) |
Managing Director |
Pirche AG |
Germany |
| Tüttenberg, Andrea R. (ActiTrexx 202010– Managing Director + Co-Founder + Prof at Univ Mainz) |
Managing Director |
ActiTrexx GmbH |
Germany |
| Tzalis, Dimitrios (Talos Chemicals 201309 CEO + Founder) |
Chief Executive Officer (CEO) |
Taros Chemicals GmbH & Co. KG |
Germany |
| Tzannis, Stelios T. (Aeovian Pharmaceuticals 201910 CEO) |
Chief Executive Officer (CEO) |
|
|
| Tzouvalis, Plato (Acrongenomics 200704 President) |
n. a. |
Acrongenomics Inc. |
United Kingdom (GB) |
| Törnsén, Maria (Passage Bio 202107– Chief Commercial Officer before Sarepta Therapeutics + Sanofi Genzyme + Shire) |
Chief Commercial Officer (CCO) |
Passage Bio Inc. (PASG) |
United States (USA) |
| Ubags, Frank (Cevec 201504– CEO before COO since 201409 before Coral BioNet + Scil Proteins + Kiadis + Rhein Biotech) |
Chief Operating Officer (COO) |
Danaher (Group) |
Germany |
| Udaka, Michitaka (Asahi Kasei 202406 Managing Director of Asahi Kasei Europe GmbH) |
Managing Director |
Asahi Kasei (Group) |
Germany |
| Udier-Blagovic, Marina (Nouscom 202002– CEO joined 201609 as COO before Versant Ventures + Novartis + McKinsey) |
Chief Operating Officer (COO) |
Nouscom (Group) |
Switzerland |
| Ueberschaar, Nico (Univ Jena 201806 Head of MS platform) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Jena (Friedrich-Schiller-Universität Jena) |
Germany |
| Uecke, Oliver (Lipotype GmbH 201410 Head Business Development + Finance) |
Business Development Manager / Strategy Manager |
Lipotype GmbH |
Germany |
| Ueda, Teruhisa (Shimadzu 201504– CEO before General Manager Analytical + Measuring Instruments division joined 1082) |
Chief Executive Officer (CEO) |
Shimadzu (Group) |
Japan |
| Ueffing, Marius (Helmholtz 201202 Head Research Unit Protein Science at Helmholtz-Zentrum München) |
Researcher (university / research institute) |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Uhl, Nikolaus (Weitnauer Rechtsanwälte 200809 Berlin) |
n. a. |
Weitnauer Partnerschaft mbB Rechtsanwälte Steuerberater |
Germany |
| Uhlmann, Karen (Omeicos Therapeutics GmbH 201312 Managing Director) |
Managing Director |
Omeicos (Group) |
Germany |
| Uhrich, Christian (Merck (DE) 202306 Principal at M Ventures) |
Principal (venture capital) |
Merck (DE) (Group) |
Netherlands |
| Ulbrich, Claudia (Cardior Therapeutics 201705– CEO before T-Cell Europe GmbH 201205 Managing Director) |
Managing Director |
Novo Group (Group) |
Germany |
| Ullerich, Lars (GNA Biosolutions GmbH 201507 Managing Director) |
Managing Director |
GNA Biosolutions GmbH |
Germany |
| Ullmann, Dirk (Evotec 202209 Global Head Drug Discovery Services before Proteros Biostructures + Evotec) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evotec (Group) |
Germany |
| Ullrich, Axel (Max Planck 201102 Director MPI for Biochemistry, Dept. of Molecular Biology) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Ullrich, Dirk (Axicorp 201105 Managing Director) |
Managing Director |
Biocon (Group) |
Germany |
| Ullrich, Matthias (Jabocs Univ 201207 Prof of Microbiology at School of Engineering and Science) |
Professor |
Schaffhausen Institute of Technology (SIT) |
Germany |
| Ulmer, Thomas (Immatics 201804– CFO before Merck (DE) as CFO of Allergopharma business unit) |
Chief Financial Officer (CFO) |
Immatics (Group) |
Germany |
| Ulmer-Eilfort, Constanze (PSP Peters, Schönberg & Partner 202303 Partner) |
Attorney / Lawyer |
PSP Peters, Schönberger & Partner |
|
| Ulmer-Weber, Manfred (SHS 202208– Managing Partner before Partner + Senior Investment Manager joined 2010) |
Managing Partner (investment firm) |
SHS Capital (Group) |
Germany |
| Ulsemer, Philippe R. R. (Acaryon GmbH 202001– Managing Director + Co-Founder) |
Managing Director |
Acaryon GmbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 83 84 85 ... 93 94 95 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
